Literature DB >> 22038951

Rapid eye movement sleep behavior disorder and subtypes in autopsy-confirmed dementia with Lewy bodies.

Brittany N Dugger1, Bradley F Boeve, Melissa E Murray, Joseph E Parisi, Hiroshige Fujishiro, Dennis W Dickson, Tanis J Ferman.   

Abstract

The purpose of this study was to determine whether dementia with Lewy bodies with and without probable rapid eye movement sleep behavior disorder differ clinically or pathologically. Patients with dementia with Lewy bodies (DLB) with probable rapid eye movement sleep behavior sleep disorder (n = 71) were compared with those without it (n = 19) on demographics, clinical variables (core features of dementia with Lewy bodies, dementia duration, rate of cognitive/motor changes), and pathologic indices (Lewy body distribution, neuritic plaque score, Braak neurofibrillary tangle stage). Individuals with probable rapid eye movement sleep behavior disorder were predominantly male (82% vs 47%) and had a shorter duration of dementia (mean, 8 vs 10 years), earlier onset of parkinsonism (mean, 2 vs 5 years), and earlier onset of visual hallucinations (mean, 3 vs 6 years). These patients also had a lower Braak neurofibrillary tangle stage (stage IV vs stage VI) and lower neuritic plaque scores (18% vs 85% frequency), but no difference in Lewy body distribution. When probable rapid eye movement sleep behavior disorder developed early (at or before dementia onset), the onset of parkinsonism and hallucinations was earlier and Braak neurofibrillary tangle stage was lower compared with those who developed the sleep disorder after dementia onset. Women with autopsy-confirmed DLB without a history of dream enactment behavior during sleep had a later onset of hallucinations and parkinsonism and a higher Braak NFT stage. Probable rapid eye movement sleep behavior disorder is associated with distinct clinical and pathologic characteristics of dementia with Lewy bodies.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Year:  2011        PMID: 22038951      PMCID: PMC3513369          DOI: 10.1002/mds.24003

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  51 in total

1.  Manifestations of Parkinson disease differ in association with REM sleep behavior disorder.

Authors:  Ronald B Postuma; Jean-Francois Gagnon; Melanie Vendette; Katia Charland; Jacques Montplaisir
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

2.  Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.

Authors:  Thomas G Beach; Charles H Adler; LihFen Lue; Lucia I Sue; Jyothi Bachalakuri; Jonette Henry-Watson; Jeanne Sasse; Sarah Boyer; Scophil Shirohi; Reed Brooks; Jennifer Eschbacher; Charles L White; Haru Akiyama; John Caviness; Holly A Shill; Donald J Connor; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2009-04-28       Impact factor: 17.088

3.  REM sleep behaviour disorder in Parkinson's disease is associated with specific motor features.

Authors:  R B Postuma; J F Gagnon; M Vendette; K Charland; J Montplaisir
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-08-05       Impact factor: 10.154

4.  Neurotoxic lesions at the ventral mesopontine junction change sleep time and muscle activity during sleep: an animal model of motor disorders in sleep.

Authors:  Y-Y Lai; K-C Hsieh; D Nguyen; J Peever; J M Siegel
Journal:  Neuroscience       Date:  2008-04-16       Impact factor: 3.590

5.  Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder.

Authors:  R B Postuma; J F Gagnon; M Vendette; M L Fantini; J Massicotte-Marquez; J Montplaisir
Journal:  Neurology       Date:  2008-12-24       Impact factor: 9.910

Review 6.  Sleep disorders in Parkinson's disease: an overview.

Authors:  Cynthia L Comella
Journal:  Mov Disord       Date:  2007-09       Impact factor: 10.338

7.  Parkinson's disease with and without REM sleep behaviour disorder: are there any clinical differences?

Authors:  Asako Yoritaka; Hideki Ohizumi; Shigeki Tanaka; Nobutaka Hattori
Journal:  Eur Neurol       Date:  2009-01-08       Impact factor: 1.710

8.  Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy.

Authors:  A M Schmeichel; L C Buchhalter; P A Low; J E Parisi; B W Boeve; P Sandroni; E E Benarroch
Journal:  Neurology       Date:  2008-01-29       Impact factor: 9.910

Review 9.  Sleep disturbances in patients with parkinsonism.

Authors:  Valérie Cochen De Cock; Marie Vidailhet; Isabelle Arnulf
Journal:  Nat Clin Pract Neurol       Date:  2008-04-08

10.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Authors:  Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

View more
  38 in total

1.  Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.

Authors:  Thomas G Beach; Charles H Adler; Geidy Serrano; Lucia I Sue; D G Walker; Brittany N Dugger; Holly A Shill; Erika Driver-Dunckley; John N Caviness; Anthony Intorcia; Jessica Filon; Sarah Scott; Angelica Garcia; Brittany Hoffman; Christine M Belden; Kathryn J Davis; Marwan N Sabbagh
Journal:  J Parkinsons Dis       Date:  2016       Impact factor: 5.568

2.  Altered functional connectivity in lesional peduncular hallucinosis with REM sleep behavior disorder.

Authors:  Maiya R Geddes; Yanmei Tie; John D E Gabrieli; Scott M McGinnis; Alexandra J Golby; Susan Whitfield-Gabrieli
Journal:  Cortex       Date:  2015-11-05       Impact factor: 4.027

Review 3.  Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease.

Authors:  Bradley F Boeve
Journal:  Lancet Neurol       Date:  2013-04-09       Impact factor: 44.182

Review 4.  Idiopathic REM sleep behaviour disorder and neurodegeneration - an update.

Authors:  Birgit Högl; Ambra Stefani; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2017-11-24       Impact factor: 42.937

Review 5.  Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer's disease.

Authors:  A J Carman; P A Dacks; R F Lane; D W Shineman; H M Fillit
Journal:  J Nutr Health Aging       Date:  2014-04       Impact factor: 4.075

6.  Environmental risk factors for REM sleep behavior disorder: a multicenter case-control study.

Authors:  R B Postuma; J Y Montplaisir; A Pelletier; Y Dauvilliers; W Oertel; A Iranzo; L Ferini-Strambi; I Arnulf; B Hogl; R Manni; T Miyamoto; G Mayer; K Stiasny-Kolster; M Puligheddu; Y Ju; P Jennum; K Sonka; J Santamaria; M L Fantini; M Zucconi; S Leu-Semenescu; B Frauscher; M Terzaghi; M Miyamoto; M M Unger; V Cochen De Cock; C Wolfson
Journal:  Neurology       Date:  2012-06-27       Impact factor: 9.910

Review 7.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

Review 8.  REM sleep behavior disorder, autonomic dysfunction and synuclein-related neurodegeneration: where do we stand?

Authors:  Giacomo Chiaro; Giovanna Calandra-Buonaura; Annagrazia Cecere; Francesco Mignani; Luisa Sambati; Giuseppe Loddo; Pietro Cortelli; Federica Provini
Journal:  Clin Auton Res       Date:  2017-09-04       Impact factor: 4.435

9.  Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.

Authors:  B F Boeve; M H Silber; T J Ferman; S C Lin; E E Benarroch; A M Schmeichel; J E Ahlskog; R J Caselli; S Jacobson; M Sabbagh; C Adler; B Woodruff; T G Beach; A Iranzo; E Gelpi; J Santamaria; E Tolosa; C Singer; D C Mash; C Luca; I Arnulf; C Duyckaerts; C H Schenck; M W Mahowald; Y Dauvilliers; N R Graff-Radford; Z K Wszolek; J E Parisi; B Dugger; M E Murray; D W Dickson
Journal:  Sleep Med       Date:  2013-03-07       Impact factor: 3.492

10.  Morbidities in rapid eye movement sleep behavior disorder.

Authors:  Poul Jennum; Geert Mayer; Yo-El Ju; Ron Postuma
Journal:  Sleep Med       Date:  2013-01-29       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.